Biotech Series A Investors & VC Firms
1627 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Oikos Ventures
MontevideoSeed–Growth
1 person
Salt Mines Advisors
Pre-Seed–Series A
1 person
SRI Ventures
Silicon ValleySeed–Series A
1 person
TeleVenture Management AS
OsloSeed–Series A
1 person
Treasure Coast Ventures
Vero BeachSeed–Series A
1 person
Unveil Pharma
BostonPre-Seed–Series A
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
Yaya Capital
MiamiSeed–Series A$300K – $5M
4 people
EMBRAPII
BrasíliaPre-Seed–Growth
ExtraVallis
Coral GablesPre-Seed–Series A
Hefei High-tech VC
HefeiSeed–Series C
Nventure
CobourgSeed–Series A$182.5K
Seoul Investment Partners
SeoulSeed–Late Stage
Stonebridge Ventures
SeoulSeries A–Series C
3 people
Strategic Innovation Fund
OttawaSeries A
The Wells Investment
SeoulSeed–Late Stage
UNSW
SydneyPre-Seed–Series A
Morningside Group
Hong KongSeed–Growth
1 person
Ausvic Capital
Hong KongPre-Seed–Series A
Egora Holding
MartinsriedSeed–Series B$5.4M
GERBER-RAUTH
MilanPre-Seed–Late Stage
Mankind Pharma
New DelhiSeries A
Union Investment Partners
SeoulSeed–Series A
VentureTECH
SelangorSeries A
Related lists
Series A Investors & VC Firms (7336)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2604)SaaS Series A Investors & VC Firms (2592)Biotech Investors & VC Firms (2483)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2314)Enterprise Software Series A Investors & VC Firms (2269)
Data sourced from public filings and firms' own websites — see our methodology.









